ARG1 and hepatocellular carcinoma: In unresectable HCC patients treated with TACE, the risk of early TACE refractoriness decreased with an increase in ARG1 expression, possibly because the increased ARG1 expression increased the catalysis and consumption of arginine and reduced the amount of arginine in the microenvironment (17).